- Home
- NXRT vs PRME Comparison
NXRT vs PRME Comparison
Compare NXRT & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXRT | PRME |
|---|---|---|
| Founded | 2014 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.2M | 666.1M |
| IPO Year | 2014 | 2022 |
Fundamental Metrics
Financial Performance| Metric | NXRT | PRME |
|---|---|---|
| Price | $28.98 | $3.48 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $31.00 | $7.56 |
| AVG Volume (30 Days) | 153.3K | ★ 1.6M |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | ★ 7.50% | N/A |
| EPS Growth | N/A | ★ 18.18 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $251,281,000.00 | $4,632,000.00 |
| Revenue This Year | $3.09 | $7.06 |
| Revenue Next Year | $3.02 | $47.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $23.79 | $1.11 |
| 52 Week High | $38.08 | $6.94 |
Technical Indicators
Market Signals| Indicator | NXRT | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 66.30 | 43.81 |
| Support Level | $27.69 | $3.17 |
| Resistance Level | $32.12 | $3.97 |
| Average True Range (ATR) | 0.82 | 0.20 |
| MACD | 0.35 | -0.03 |
| Stochastic Oscillator | 89.06 | 18.38 |
Price Performance
Historical ComparisonAbout NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. The trust's objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.